1 / 17

Biomaterials, Drug Delivery, Nanotechnology and Bioengineering

Biomaterials, Drug Delivery, Nanotechnology and Bioengineering. Nicholas A. Peppas Center for Biomaterials, Drug Delivery, Bionanotechnology and Molecular Recognition Departments of Chemical Engineering, Biomedical Engineering, and Division of Pharmaceutics

sinead
Télécharger la présentation

Biomaterials, Drug Delivery, Nanotechnology and Bioengineering

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Biomaterials, Drug Delivery, Nanotechnology and Bioengineering Nicholas A. Peppas Center for Biomaterials, Drug Delivery, Bionanotechnology and Molecular Recognition Departments of Chemical Engineering, Biomedical Engineering, and Division of Pharmaceutics The University of Texas at Austin Austin, Texas 78712, USA

  2. “Smart” Drug Delivery • The future of drug delivery systems will involve smart systems • These will address the issue of keeping the drug at the desired therapeutic level in the body thus avoiding frequent administration • Systems use detection of chemical signals in the body to prompt the release of drugs • The ultimate goal is to administer drugs at the right time, at the right dose anywhere in the body with specificity and efficiency

  3. Stomach pH ~2 Tight Junction Polymeric Carrier Protein Proteolitic Mucosa Enzymes Oral Delivery of Proteins Challenges • Protection of the drug from: • The acidic environment in the stomach • Degradation by proteolytic enzymes in the GI tract • Penetration and absorption of drug across the intestinal mucosa and epithelium

  4. CH3 CH3 x H2C C H2C C C O [ O HOOC CH2CH2 ]n OCH3 CH3 CH3 H2C C H2C C C O [ O -OOC CH2CH2 ]n OCH3 Complexation and pH Responsive Hydrogels Complexed Small mesh sizeLow pH Protect drug Release drug Uncomplexed Increased mesh size High pH x

  5. In Vivo Study with pH-Responsive Complexation Hydrogels • P(MAA-g-EG) microspheres loaded with insulin • Administered to diabetic rats 40% drop in blood glucose levels

  6. NIH 2-3 positions

  7. NIH/NCI 1-2 positions

  8. NSF 1 position

  9. System-Responsive Therapy:Control-Based Design of Biomedical SystemsConfigurational Biomimetic Imprinting Making “artificial locks” for “molecular keys” Molecular key (template molecule) • Small molecules • Drug substances, amino acids, steroid hormones • Large molecules • Nucleic acids, proteins • Cells and viruses Lock (polymer building blocks) • Functional monomers • Cross-linkers

  10. Configurational Biomimetic Imprinting Solvent Initiator Monomers Polymerization Template Extraction and drying

  11. Laser beam Polymer Silicon Change in analyte, pH, temperature etc.  hydrogel swells θ Laser beam φ φ > θ BioMEMS Sensor Platform • Pattern environmentally responsive hydrogels onto silicon microcantilevers to create a BioMEMS/MEMS sensor device.

  12. System-Responsive Therapy:A Bright Future • Need for advanced intelligent materials, more reliable devices, miniaturized systems • Society asks for improved treatment of disease, advanced detection and therapy, and cost effective processes • Improvement of quality of life is important

  13. David Bill Cody Brandon Maggie Diane Jenny Amey Mary Insulin Cancer siRNA Recognitive External Triggering

More Related